相关实验视频

Updated: Jan 18, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

有条件的IL4I1非激活触发了与瘤相关的巨细胞重编程和CD8+T细胞的重新激活,以控制黑色素瘤的进展

Malvina Seradj¹, Saniya Kari¹, Anna Llebaria-Fabrias¹

¹Institut Cochin Paris France.

Cancer immunology research

|January 15, 2026

概括

在瘤相关巨细胞 (TAMs) 中的酶IL-4诱导基因1 (IL4I1) 促进黑色素瘤免疫逃生. 抑制IL4I1可以增强抗瘤免疫力,并延缓黑色素瘤的进展,从而提供新的免疫疗法策略.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物化学生物化学

背景情况:

瘤相关巨细胞 (TAMs) 是癌症中的关键免疫细胞,通常与预后不佳有关.
通过免疫抑制酶表达,TAMs可以通过免疫抑制酶表达来采用突瘤特性.
IL-4诱导基因1 (IL4I1) 是一种酶,涉及瘤微环境中的免疫调节.

研究的目的:

调查TAMs表达的IL4I1在黑色素瘤进展中的作用.
确定IL4I1对TAM功能和抗瘤免疫力的影响.
探索IL4I1作为黑色素瘤免疫治疗中的潜在治疗点.

主要方法:

在小鼠模型中分析TAMs中的IL4I1表达在自发黑色素瘤进展期间.
在巨细胞中遗传删除IL4I1,以评估其对瘤生长和转移的体内影响.
药理上阻断IL4I1活动.
评估TAM抗原呈现能力和CD8+T细胞功能.

主要成果:

在黑色素瘤进展期间,TAM子集中的IL4I1表达被上调,可通过细胞因子同中和控制.
宏细胞特异性IL4I1删除显著延迟了瘤的发病和减少了转移性传播.
向IL4I1增强了TAM抗原呈现,并恢复了CD8+ T细胞的增殖和细胞毒性.
化学IL4I1阻断部分复制了这些抗瘤效应.

结论:

在黑色素瘤中,IL4I1在TAM介导的免疫逃避中发挥着关键作用.
抑制IL4I1是恢复黑色素瘤抗瘤免疫力的有希望的策略.
针对TAM中的IL4I1具有促进癌症免疫疗法的潜力,特别是在IL4I1表达的人类瘤中.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...